Outlook Therapeutics, Inc. (OTLK) › Total LiabilitiesOutlook Therapeutics, Inc. (OTLK) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $62.56M2016: $30.58M2017: $51.46M2018: $43.09M2019: $27.90M2020: $16.91M2021: $18.20M2022: $19.79M2023: $46.74M2024: $101.90M2025: $50.77M$50.77M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$50.77M-50.2%2024$101.90M+118.0%2023$46.74M+136.2%2022$19.79M+8.7%2021$18.20M+7.7%2020$16.91M-39.4%2019$27.90M-35.2%2018$43.09M-16.3%2017$51.46M+68.3%2016$30.58M-51.1%2015$62.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share